These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24995870)

  • 1. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life.
    Thevenon J; Milh M; Feillet F; St-Onge J; Duffourd Y; Jugé C; Roubertie A; Héron D; Mignot C; Raffo E; Isidor B; Wahlen S; Sanlaville D; Villeneuve N; Darmency-Stamboul V; Toutain A; Lefebvre M; Chouchane M; Huet F; Lafon A; de Saint Martin A; Lesca G; El Chehadeh S; Thauvin-Robinet C; Masurel-Paulet A; Odent S; Villard L; Philippe C; Faivre L; Rivière JB
    Am J Hum Genet; 2014 Jul; 95(1):113-20. PubMed ID: 24995870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
    Hardies K; de Kovel CG; Weckhuysen S; Asselbergh B; Geuens T; Deconinck T; Azmi A; May P; Brilstra E; Becker F; Barisic N; Craiu D; Braun KP; Lal D; Thiele H; Schubert J; Weber Y; van 't Slot R; Nürnberg P; Balling R; Timmerman V; Lerche H; Maudsley S; Helbig I; Suls A; Koeleman BP; De Jonghe P;
    Brain; 2015 Nov; 138(Pt 11):3238-50. PubMed ID: 26384929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene.
    Matricardi S; De Liso P; Freri E; Costa P; Castellotti B; Magri S; Gellera C; Granata T; Musante L; Lesca G; Oertel J; Craiu D; Hammer TB; Møller RS; Barisic N; Abou Jamra R; Polster T; Vigevano F; Marini C
    Epilepsia; 2020 Nov; 61(11):2474-2485. PubMed ID: 33063863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC13A5 is the second gene associated with Kohlschütter-Tönz syndrome.
    Schossig A; Bloch-Zupan A; Lussi A; Wolf NI; Raskin S; Cohen M; Giuliano F; Jurgens J; Krabichler B; Koolen DA; de Macena Sobreira NL; Maurer E; Muller-Bolla M; Penzien J; Zschocke J; Kapferer-Seebacher I
    J Med Genet; 2017 Jan; 54(1):54-62. PubMed ID: 27600704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Homozygous Variants of SLC13A5 Expand the Functional Heterogeneity of a Homogeneous Syndrome of Early Infantile Epileptic Encephalopathy.
    Alsemari A; Guzmán-Vega FJ; Meyer BF; Arold ST
    Pediatr Neurol; 2024 Feb; 151():68-72. PubMed ID: 38113697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy.
    Assoum M; Philippe C; Isidor B; Perrin L; Makrythanasis P; Sondheimer N; Paris C; Douglas J; Lesca G; Antonarakis S; Hamamy H; Jouan T; Duffourd Y; Auvin S; Saunier A; Begtrup A; Nowak C; Chatron N; Ville D; Mireskandari K; Milani P; Jonveaux P; Lemeur G; Milh M; Amamoto M; Kato M; Nakashima M; Miyake N; Matsumoto N; Masri A; Thauvin-Robinet C; Rivière JB; Faivre L; Thevenon J
    Am J Hum Genet; 2016 Dec; 99(6):1368-1376. PubMed ID: 27889060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel homozygous SLC13A5 whole-gene deletion generated by Alu/Alu-mediated rearrangement in an Iraqi family with epileptic encephalopathy.
    Duan R; Saadi NW; Grochowski CM; Bhadila G; Faridoun A; Mitani T; Du H; Fatih JM; Jhangiani SN; Akdemir ZC; Gibbs RA; Pehlivan D; Posey JE; Marafi D; Lupski JR
    Am J Med Genet A; 2021 Jul; 185(7):1972-1980. PubMed ID: 33797191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
    Goodspeed K; Liu JS; Nye KL; Prasad S; Sadhu C; Tavakkoli F; Bilder DA; Minassian BA; Bailey RM
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures.
    Saito T; Ishii A; Sugai K; Sasaki M; Hirose S
    Clin Genet; 2017 Dec; 92(6):654-658. PubMed ID: 28477354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy.
    Santalucia R; Vilain C; Soblet J; De Laet C; Vuckovic A; König J; Aeby A
    Ann Clin Transl Neurol; 2022 Jul; 9(7):1095-1099. PubMed ID: 35633140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.
    Henke C; Töllner K; van Dijk RM; Miljanovic N; Cordes T; Twele F; Bröer S; Ziesak V; Rohde M; Hauck SM; Vogel C; Welzel L; Schumann T; Willmes DM; Kurzbach A; El-Agroudy NN; Bornstein SR; Schneider SA; Jordan J; Potschka H; Metallo CM; Köhling R; Birkenfeld AL; Löscher W
    Neurobiol Dis; 2020 Sep; 143():105018. PubMed ID: 32682952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
    Kopel J; Grooms A; Ganapathy V; Clothier J
    Psychiatr Genet; 2021 Feb; 31(1):32-35. PubMed ID: 33290383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay.
    Klotz J; Porter BE; Colas C; Schlessinger A; Pajor AM
    Mol Med; 2016 May; 22():310-21. PubMed ID: 27261973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, radiological, and genetic characterization of
    AlQudairy H; AlDhalaan H; AlRuways S; AlMutairi N; AlNakiyah M; AlGhofaili R; AlBakheet A; Alomrani A; Alharbi OA; Tous E; AlSayed M; AlZaidan H; AlRasheed MM; AlOdaib A; Kaya N
    Front Pediatr; 2022; 10():1051534. PubMed ID: 36923948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and epileptic encephalopathy 82 (DEE82) with novel compound heterozygous mutations of GOT2 gene.
    Çapan ÖY; Türkdoğan D; Atalay S; Çağlayan HS
    Seizure; 2024 Mar; 116():126-132. PubMed ID: 37977948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations.
    Weeke LC; Brilstra E; Braun KP; Zonneveld-Huijssoon E; Salomons GS; Koeleman BP; van Gassen KL; van Straaten HL; Craiu D; de Vries LS
    Eur J Paediatr Neurol; 2017 Mar; 21(2):396-403. PubMed ID: 27913086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle.
    Bainbridge MN; Cooney E; Miller M; Kennedy AD; Wulff JE; Donti T; Jhangiani SN; Gibbs RA; Elsea SH; Porter BE; Graham BH
    Mol Genet Metab; 2017 Aug; 121(4):314-319. PubMed ID: 28673551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAT1 encephalopathy: a recessive cause of epilepsy of infancy with migrating focal seizures.
    Scheffer IE; Boysen KE; Schneider AL; Myers CT; Mehaffey MG; Rochtus AM; Yuen YP; Ronen GM; Chak WK; Gill D; Poduri A; Mefford HC
    Dev Med Child Neurol; 2020 Sep; 62(9):1096-1099. PubMed ID: 31868227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.
    Ben-Salem S; Gleeson JG; Al-Shamsi AM; Islam B; Hertecant J; Ali BR; Al-Gazali L
    Metab Brain Dis; 2015 Jun; 30(3):687-94. PubMed ID: 25227173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.